Mariangela Panebianco

Mariangela Panebianco

Auto-generated profile, based on publicly available information

Mariangela Panebianco

Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2006 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
VITTORIO CALABRESEVITTORIO CALABRESE
VITTORIO CALABRESE
EGEleonora Guagliano
Eleonora Guagliano
MSMaria Sapienza
Maria Sapienza
MPMariangela Panebianco
Mariangela Panebianco
SCStella Calafato
Stella Calafato
ASAnnamaria Giuffrida Stella
Annamaria Giuffrida Stella

7 June 2020 in Neurological Sciences
Verified
Journal Article
Open access
PDF file
MPM. Panebianco
M. Panebianco
RMRosario Marchese-Ragona
Rosario Marchese-Ragona
Masiero StefanoMasiero Stefano
Masiero Stefano
DRDomenico Antonio Restivo
Domenico Antonio Restivo
Dysphagia is defined as an impairment of this complex and integrated sensorimotor system. It is estimated that 400,000 to 800,000 individuals worldwide develop neurogenic dysphagia per year. Neurogenic dysphagia is typically occurring in patients with neurological disease of different etiologies. A correct and early diagnosis and an appropriate management of dysphagia could be useful for improving patient’s quality of life and may help to prevent or delay death. In the present review, we discuss thoroughly the anatomy and physiology of swallowing and also the pathophysiological mechanisms involved in impaired swallowing, as well as the diagnosis, management, and potential treatments of neurogenic dysphagia. Assessment of neurogenic dysphagia includes medical history, physical exam, and instrumental examinations (fiberoptic endoscopic evaluation of swallowing, videofluoroscopic swallowing study, electromyography). Pharmacological treatment of these problems includes oral anticholinergic drugs. Surgical myotomy of the cricopharyngeal muscle showed an important improvement of oropharyngeal dysphagia associated to upper esophageal sphincter hyperactivity. Chemical myotomy of the upper esophageal sphincter by local injections of botulinum toxin type A into the cricopharyngeal muscle has been proposed as an alternative less invasive and less unsafe than surgical myotomy.

3 April 2015 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
MPMariangela Panebianco
Mariangela Panebianco
ARAlexandra Rigby
Alexandra Rigby
JWJennifer Weston
Jennifer Weston
AMAnthony G Marson
Anthony G Marson

15 October 2019 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
PDF file
MCMaria Cristina Costanzo
Maria Cristina Costanzo
CAChiara Arcidiacono
Chiara Arcidiacono
ARAlessandro Rodolico
Alessandro Rodolico
MPMariangela Panebianco
Mariangela Panebianco
EAEugenio Aguglia
Eugenio Aguglia
Maria Salvina SignorelliMaria Salvina Signorelli
Maria Salvina Signorelli

24 February 2016 in Acta Neurologica Belgica
Verified
Journal Article
Closed access
PDF file
MPMariangela Panebianco
Mariangela Panebianco
CZChiara Zavanone
Chiara Zavanone
SDSophie Dupont
Sophie Dupont
DRDomenico Antonio Restivo
Domenico Antonio Restivo
APAntonino Pavone
Antonino Pavone

1 April 2017 in Revue Neurologique
Verified
Journal Article
Closed access
CZC. Zavanone
C. Zavanone
MPM. Panebianco
M. Panebianco
MYM. Yger
M. Yger
ABA. Borden
A. Borden
DRDomenico Antonio Restivo
Domenico Antonio Restivo
SDS. Dupont
S. Dupont